THE EFFECT OF CORONARY ARTERY DISEASE SEVERITY AND REVASCULARIZATION COMPLETENESS ON TWO YEARS CLINICAL OUTCOMES IN PATIENTS WITH SEVERE SYMPTOMATIC AORTIC STENOSIS UNDERGOING TRANSCATETHER AORTIC VALVE IMPLANTATION  by Vitberg, Guy et al.
TCT@ACC-i2: Interventional Cardiology
A1774
JACC March 17, 2015
Volume 65, Issue 10S
the eFFeCt oF Coronary artery disease severity and revasCUlariZation 
Completeness on two years CliniCal oUtComes in patients with severe symptomatiC 
aortiC stenosis UnderGoinG transCatether aortiC valve implantation
Poster Contributions
Poster Hall B1
Saturday, March 14, 2015, 3:45 p.m.-4:30 p.m.
Session Title: Coronary II
Abstract Category: 30. TCT@ACC-i2: Aortic Valve Disease
Presentation Number: 2101-287
Authors: Guy Vitberg, Emmanuel Harari, Ifat Lavi, Pablo Codner, Hana Vaknin-Assa, Abid Assali, Ran Kornowski, Department of 
Cardiology, Rabin Medical Center, Petach Tikva, Israel
background:  Patients undergoing transcatheter aortic valve implantation (TAVI) have high prevalence of coronary artery disease (CAD), 
which is associated with worse outcomes. Recent data suggests that it is CAD severity, as expressed by the SYNTAX score (SS) that is 
correlated to clinical outcomes. We sought to evaluate the effect of CAD severity and of the pre TAVI completeness of revscularization on 
clinical outcomes in TAVI patients using the SS, the clinical SS (cSS) and the residual SYNTAX score (rSS).
methods:  A prospective registry of consecutive patients undergoing TAVI at our institution from 8/2008 to 11/2013 (n=287). Patients 
were classified as having concomitant CAD or no CAD and the CAD patients were stratified according to SS and cSS levels, in addition, 
the completeness of pre TAVI revascularization was stratified using the rSS. We compared 2 year clinical outcomes (death/myocardial 
infarction/cerebrovascular accident) between the no CAD vs. the CAD group stratified according to the SS/cSS/rSS using a cox 
proportional hazard ratio model adjusted for major clinical and demographic variables.
results:  49 patients (17.1%) had CAD, these patients had a higher rate of the primary endpoint at 2 years (28.3% vs. 16.1% p=0.026), but 
when stratified by CAD severity - the difference was solely driven by the high severity CAD groups (75% vs. 16.1% p=0.002 for SS>22 and 
41.2% vs.16.1% p=0.001 for cSS>63), whereas low severity CAD patients (SS<22 , cSS 8 had significantly higher incidence of the primary 
outcome in the overall CAD group (78.6% vs. 16.1% p<0.001). patients with a rSS<8 did not have worse outcomes than patients with no 
CAD.
Conclusion:   In patients undergoing TAVI, it is CAD severity (as assessed by the SS/cSS) that is associated with worse prognosis and not 
the mere presence of CAD. More complete revascularization (to a rSS<8) attenuates the effect of CAD on clinical outcomes. The SS and 
cSS can help identify patients at high risk for adverse events, who can benefit from more aggressive and complete revascularization prior 
to TAVI.
